Mark Paul Goldberg, MD
Current Position
Professor, Neurology, Neurobiology, and Biomedical Engineering
Attending Physician, Stroke Service at Barnes-Jewish Hospital
Director, Hope Center for Neurological Disorders
Director: Internet Stroke Center (web education project):
www.neuro.wustl.edu/smart/
Specialty Areas
Neurology - Adult
Cerebrovascular Disease
Stroke
Mailing Address
|
Washington University School of Medicine
Department of Neurology
660 South Euclid Ave., Campus Box 8111
St. Louis,
MO
63110
|
Academic Office
|
Washington University School of Medicine
Department of Neurology
660 South Euclid
St Louis ,
MO
63110
314-362-9460
Fax:
314-362-9462
|
Areas of Clinical Interest
IN-PATIENT CARE ONLY in the Stroke Service. Stroke, cerebrovascular diseases, cerebral ischemia, neuronal degeneration
For information on the Washington University Stroke Center.
Board Certification
Neurology
--
Certified
This physician is not able to accept new patients at this time.
Medical Education
B.A.: Biology, Harvard University, Cambridge, Massachusetts
, 1980
Medical Degree: Columbia University College Of Physicians & Surgeons, New York, NY
, 1984
Residency: Neurology, Stanford University Hospital, Stanford, California
, 1987
Chief Resident: Neurology, Stanford University Hospital, Stanford, California
, 1990
Fellowship: Neurology, Stanford University School of Medicine, Stanford, California
, 1991
Hospital Affiliations
Barnes-Jewish Hospital
ConnectCare Hospital
Major or Recent Publications/Awards
Distinctions and Awards
Clinical Lecturer of the Year Award, Washington University Medical School, 2005 and 2006
President, American Heart Association, Greater St. Louis Division, 2002-2004
Mary Jane Thaman Award, 2001
Established Investigator Award, American Heart Association, 1999
William Randolph Hearst Foundation Award, American Heart Association, 1995
First Independent Research and Support Transition (FIRST) Award, National Institute of Neurologic Disorders and Stroke, NIH, 1993
Clinical Investigator Development Award (CIDA), National Institute of Neurologic Disorders and Stroke, NIH, 1992
Fellow, Stroke Council, American Heart Association, 1991
Sandoz Award for Pharmacology Research, 1990
Journal Articles and Book Chapters
McCarran, W., Goldberg, M.P. White matter axon vulnerability to AMPA/kainate receptor-mediated ischemic injury is developmentally regulated. J Neurosci., 27:4220-4229, 2007
Goldberg, M.P. and Ransom, B.R. New light on white matter. Stroke, 34: 330-332, 2003
Dewar, D., Underhill, S.M. Goldberg, M.P. Oligodendrocytes and ischemic brain injury. J. Cereb. Blood Flow Metab., 23: 263-274, 2003
Istas, A.D., Labit, J.L., Bauman, A.M. Goldberg, M.P. The Stroke Trials Directory: an online registry of clinical trials in cerebrovascular disease. Semin.
Cerebrovasc. Dis., 3: 48-53, 2003
Ransom, B.R., Acahrya, A.B. Goldberg, M.P. Molecular pathophysiology of white matter anoxic-ischemic injury. In: Stroke, 4th edition (H.J.M. Barnett et al., eds.). Churchill Livingstone (Philadelphia), 867-881, 2004
Ness, J.K. and Goldberg, M.P. Oligodendrocyte and Schwann cell injury. In: Neuroglia, 2nd edition. (B.R. Ransom and H. Kettenman, eds.), Oxford University Press, 430-442, 2005
Ness J.K., Valentino M., McIver S.R., Goldberg M.P. Identification of oligodendrocytes in experimental disease models. Glia, 50:321-328, 2005
Goldberg, M.P. New approaches to clinical trials in neuroprotection. 24th Princeton Conference. Stroke, 38:789-790, 2007
Hasbani MJ, Underhill SM, de Erausquin G, Goldberg MP. Synapse loss and regeneration: A mechanism for functional decline and recovery after cerebral ischemia? The Neuroscientist 2000; 6:110-119
McDonald JW, Althomsons SP, Hyrc KH, Choi DW, Goldberg MP. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nature Medicine 1998; 4:291-297
For more articles and abstracts, take this off-site link to the National Library of Medicine Pub Med page for Dr. Mark P. Goldberg